{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:51:12Z","timestamp":1790229072618,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00673","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T04:24:18Z","timestamp":1523247858000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment"],"prefix":"10.3389","volume":"9","author":[{"given":"Priscila C. B.","family":"Halicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds A.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C. G.","family":"De Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula F.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina P.","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane dos S. C.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do C. F. R.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro E. A.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.it.2014.04.006","article-title":"Tuberculosis vaccines \u2013 rethinking the current paradigm.","volume":"35","author":"Andersen","year":"2014","journal-title":"Trends Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.","volume":"170","author":"Ansar Ahmed","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ja.2012.54","article-title":"Thoughts and facts about antibiotics: where we are now and where we are heading.","volume":"65","author":"B\u00e9rdy","year":"2012","journal-title":"J. Antibiot."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1128\/AAC.02293-13","article-title":"Energy metabolism and drug efflux in Mycobacterium tuberculosis.","volume":"58","author":"Black","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B5","first-page":"507","article-title":"Antimicrobial evaluation of quinones and heterocyclic compounds against Mycobacterium marinum, M. kansasii and M. abscessus.","volume":"31","author":"Cantos","year":"2012","journal-title":"Lat. Am. J. Pharm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tube.2010.06.001","article-title":"Activity of \u03b2-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis.","volume":"90","author":"Coelho","year":"2010","journal-title":"Tuberculosis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1590\/S0100-40422003000300019","article-title":"Um panorama atual da qu\u00edmica e da farmacologia de naftoquinonas, com \u00eanfase na \u03b2-Lapachona e derivados.","volume":"26","author":"Da Silva","year":"2003","journal-title":"Quim. Nova"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1590\/S0103-50532001000300003","article-title":"Trypanocidal activity of isolated naphthoquinones from Tabebuia and some heterocyclic derivatives: a review from an interdisciplinary study.","volume":"12","author":"De Moura","year":"2001","journal-title":"J. Braz. Chem. Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/ptr.5090","article-title":"Antitubercular and antibacterial activity of quinonoid natural products against multi-drug resistant clinical isolates.","volume":"28","author":"Dey","year":"2014","journal-title":"Phyther. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ardp.200900162","article-title":"Synthesis of alpha- and beta-pyran naphthoquinones as a new class of antitubercular agents.","volume":"343","author":"Ferreira","year":"2010","journal-title":"Arch. Pharm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1021\/ja01311a030","article-title":"The reaction of hydrazoic acid with the naphthoquinones.","volume":"57","author":"Fieser","year":"1935","journal-title":"J. Am. Chem. Soc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bmcl.2013.12.049","article-title":"Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.","volume":"24","author":"Fiorito","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.exppara.2013.07.021","article-title":"Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani.","volume":"135","author":"Hazra","year":"2013","journal-title":"Exp. Parasitol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1093\/jac\/dkw244","article-title":"Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death.","volume":"71","author":"Heikal","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.addr.2016.04.026","article-title":"New agents for the treatment of drug-resistant Mycobacterium tuberculosis.","volume":"102","author":"Hoagland","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2017.126","article-title":"New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.","author":"Igarashi","year":"2017","journal-title":"J. Antibiot."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.5935\/0103-5053.20150067","article-title":"On the search for potential antimycobacterial drugs: synthesis of naphthoquinoidal, phenazinic and 1,2,3-triazolic compounds and evaluation against Mycobacterium tuberculosis.","volume":"26","author":"Jardim","year":"2015","journal-title":"J. Braz. Chem. Soc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1074\/jbc.M112.419069","article-title":"The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.","volume":"288","author":"Karkare","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution.","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.1021\/jo200354u","article-title":"C-H functionalization of 1,4-naphthoquinone by oxidative coupling with anilines in the presence of a catalytic quantity of copper(II) acetate.","volume":"76","author":"Lisboa","year":"2011","journal-title":"J. Org. Chem."},{"key":"B22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.17533\/udea.vitae.17322","article-title":"Naphthoquinones: biological properties and synthesis of lawsone and derivatives \u2014 A structured review.","volume":"21","author":"L\u00f3pez-L\u00f3pez","year":"2014","journal-title":"Vitae"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s00044-011-9741-y","article-title":"Docking study on trametenolic acid B as a \u03b1-glucosidase inhibitor.","volume":"21","author":"Luo","year":"2012","journal-title":"Med. Chem. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(10)60359-9","article-title":"Global tuberculosis drug development pipeline: the need and the reality.","volume":"375","author":"Ma","year":"2010","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/S0036-46652015000300003","article-title":"Anthelmintic activity of lapachol, \u03b2-lapachone and its derivatives against Toxocara canis larvae.","volume":"57","author":"Mata-Santos","year":"2015","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"B26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1747-0285.2010.00987.x","article-title":"Inhibition of mycobacterial growth by plumbagin derivatives.","volume":"76","author":"Mathew","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"B27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3998\/ark.5550190.0009.f17","article-title":"Synthesis and biological evaluation of substituted naphthoquinone derivatives as potent antimycobacterial agents.","volume":"2008","author":"Mital","year":"2008","journal-title":"ARKIVOC"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/mmi.13606","article-title":"Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.","volume":"103","author":"Molodtsov","year":"2017","journal-title":"Mol. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093698","article-title":"Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis.","volume":"9","author":"Neto","year":"2014","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014.","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1128\/AAC.45.7.1943-1946.2001","article-title":"Search for new drugs for treatment of tuberculosis.","volume":"45","author":"Orme","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.2174\/092986709788186066","article-title":"New anti-tuberculosis drugs: strategies, sources and new molecules.","volume":"16","author":"Palomino","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"B34","first-page":"137","article-title":"\u201cAn approach to the search for new drugs against tuberculosis,\u201d in","author":"Pavan","year":"2012","journal-title":"Understanding Tuberculosis \u2013 New Approaches to Fighting against Drug Resistance"},{"key":"B35","first-page":"74","article-title":"Trypanocidal activity of synthetic heterocyclic derivatives of active quinones from Tabebuia sp.","volume":"47","author":"Pinto","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12691\/ajmbr-1-1-3","article-title":"Antimicrobial activities of the henna extract and some synthetic naphthoquinones derivatives.","volume":"1","author":"Rahmoun","year":"2013","journal-title":"Am. J. Med. Biol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.","volume":"79","author":"Ramaswamy","year":"1998","journal-title":"Tuber. Lung Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1590\/S0100-879X2002000700008","article-title":"In vitro antimicrobial activity of a new series of 1,4-naphthoquinones.","volume":"35","author":"Riffel","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ijantimicag.2016.11.024","article-title":"In vitro and in silico analysis of the efficiency of tetrahydropyridines as drug efflux inhibitors in Escherichia coli.","volume":"49","author":"Silva","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B40","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.67.9.4586-4593.1999","article-title":"Assessment of immunity to mycobacterial infection with luciferase reporter constructs.","volume":"67","author":"Snewin","year":"1999","journal-title":"Infect. Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/13102818.2014.927200","article-title":"Quality control and safety assessment of BCG vaccines in the post-genomic era.","volume":"28","author":"Stefanova","year":"2014","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"B42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pupt.2013.08.001","article-title":"Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.","volume":"27","author":"Uc-Cach\u00f3n","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B43","year":"2017","journal-title":"WHO Global Tuberculosis Report 2017."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1306\/E4FD4657-1732-11D7-8645000102C1865D","article-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard-second edition.","volume":"26","author":"Woods","year":"2011","journal-title":"Clin. Lab. Stand. Inst."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:05:47Z","timestamp":1693613147000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":44,"alternative-id":["10.3389\/fmicb.2018.00673"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00673","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"article-number":"673"}}